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Objective: During infection like sepsis, myeloperoxidase (MPO) enzyme will be generated from the neutrophil. This enzyme will catalyze the 
oxidation of halide or pseudohalide (Cl, I-, SCN, and Br-) using hydrogen peroxide (H2O2). However, the mechanism by which oxidation of these several 
cosubstrates in neonatal sepsis is unknown. Here, we have compared the kinetic parameter of MPO in saliva of newborn at risk of sepsis with or 
without the presence of these several cosubstrates.
Methods: In this experiment, saliva samples were taken from newborn in health (n = 20) and risk of sepsis (n = 20). Saliva samples from each group 
then homogenized and divided into four groups. Group 1 served as control which contains saliva+H2O2; Group 2 contains saliva+H2O2+Cl−; Group 3 
contains saliva+H2O2+I−; and Group 4 contains saliva+H2O2+SCN−. After 1 h incubation, the kinetic parameters (Km and Vmax) were analyzed.
Results: The result shows that in sepsis condition, compared without the presence of some cosubstrates, it seems the addition of some cosubstrate 
will increase the affinity between MPO, H2O2, and the cosubstrate. Between these three cosubstrates, it seems in sepsis condition MPO will oxidize Cl−.
Conclusion: In sepsis condition, MPO works by a common mechanism, that is, oxidizing Cl− to hypochlorous acid than another cosubstrate.
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INTRODUCTION
Neonatal sepsis (NS) is still a problem in the worldwide because it is 
one of the leading causes of neonatal death. It is estimated that more 
than 40% death of children under-5 years old occur in neonates, and 
each year there are 3.1 million neonates who die in the world [1]. 
The death of the neonate is mostly caused by NS. NS is responsible 
for 30–50% of all total neonatal deaths, especially in developing 
countries [2].
NS is a clinical syndrome which is characterized by a hemodynamic, 
respiratory, and metabolic disturbance process due to systemic 
infection that can trigger an abnormal systemic inflammatory response 
syndrome in infants [3,4]. The signs and symptoms of NS are varied 
and not specific. This causes the diagnosis of NS to be difficult. Until 
now, only blood culture can be a definitive diagnosis for NS, but as it 
is known, blood culture takes a long time and is quite expensive. The 
difficulties of this diagnosis make some of clinicians used “Suspected 
sepsis” to diagnoses NS before the blood culture results [5].
The pathomechanism of NS is still unclear, but several studies have 
suggested that myeloperoxidase (MPO) enzyme was involved in these 
pathomechanism. Our previous result study shows that the level of 
MPO was significantly higher in saliva of newborn with risk of sepsis 
compared to healthy newborn [6]. The MPO level elevation in NS is 
thought to be caused by an immune and inflammatory response during 
NS. This response was important in these time, because it plays an 
important role in killing invading parasites and pathogens [5].
MPO is a heme-containing enzyme which is produced by neutrophils 
during phagocytosis. MPO plays an important role in killing 
pathogens through the formation of reactive oxidants which acts 
as an antimicrobial [7,8]. Furthermore, because MPO is one of the 
peroxidases family enzyme, it also can act as a catalyst of hydrogen 
peroxide (H2O2) removal, depending on the conditions under which 
it operates. If the MPO plays a role in the defense mechanism against 
the pathogen, MPO will use H2O2 and halide (iodide, bromide, chloride, 
and thiocyanate; I, Br, Cl, and SCN) to produce pseudo-halide such as 
hypoiodous acid (HOI), hypobromous acid, hypochlorous acid (HOCl), 
and hypothiocyanite acid (HOSCN). Conversely, if the MPO plays a role 
for H2O2 removal, then the MPO will catalyze the change of H2O2 into 
water (H2O) and oxygen (O2) [9,10].
Study of kinetics parameters of an enzyme is important to explain the 
work mechanism of the enzyme. From this point of view, it is important 
to know the kinetic parameters of the MPO in NS considering that many 
reactions catalyzed by MPO. Due to important role of MPO in NS, the 
work mechanism in these diseases has attracted much attention. In 
this regard and for better understanding of the possible mechanisms 
of MPO with the presence of some cosubstrates (I, Cl, and SCN) in NS, 




This was a prospective study conducted from December 2016 to June 
2017. Ethical approval was obtained from the Ethics Commission of 
the Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, 
South Kalimantan, Indonesia (approval number: 2010019). Written 
informed consent was obtained from all guardians on behalf of 
the newborn participants involved in the study. Patients who were 
participated in this study are newborn with risk of SN (n = 15) based on 
The American Congress of Obstetricians and Gynaecologist guidelines 
criteria for NS. Patients who were participated must at least have 1 
major criterion or 2 minor criteria according to these criteria. Healthy 
newborns (n = 15) were included as controls.
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Saliva samples collection
The patient’s salivary sample is taken from the mouth of the newborn at 
the time of clearing the oral cavity using a sterile polypropylene transfer 
pipettes. The saliva was taken by giving 0.9% NaCl solution slowly using 
the transfer pipettes at the bottom of the patient’s tongue and then the 
mixture of the saliva and NaCl was taken again as much as 5 ml. Samples 
were transported on ice to the laboratory where they were centrifuged 
at 176 g for 5 min and the supernatants stored until further analysis.
Experimental section
Samples were divided into four groups from each condition (health and 
risk of sepsis). Group 1 contained healthy/sepsis newborn saliva + H2O2 
and SN saliva + H2O2, respectively. Group 2 contained healthy/sepsis 
newborn saliva + H2O2 + 0.1 M of NaCl and SN saliva + H2O2 + 0.1 M of 
NaCl, respectively. Group 3 contained healthy/sepsis newborn saliva + 
H2O2 + 0.1 M of KI and SN saliva + H2O2 + 0.1 M of KI, respectively. Group 
4 contained healthy newborn saliva + H2O2 + 0.1 M of SCN and SN saliva 
+ H2O2 + 0.1 M of SCN, respectively.
MPO activity analysis
MPO activity was measured by spectrophotometric using o-dianisidine 
(Sigma-Aldrich) and H2O2. In the presence of H2O2 as oxidizing agents, 
MPO catalyzes the oxidation of o-dianisidine yielding a brown-colored 
product, oxidized o-dianisidine, with a maximum absorbance at 
470 nm. One unit (U) of MPO activity was defined degrading 1 µmol of 
H2O2 per minute at 25°C [11].
MPO kinetic parameters analysis
Kinetic parameters were determined using five different concentrations of 
the substrate, H2O2. Substrate concentrations are 6.25, 12.5, 25, and 50 mM 
of H2O2. The kinetic parameters, Vmax, and Km, were determined using the 
Lineweaver–Burk version of the Michaelis–Menten equation, as follows:
1 km 1 1
V Vmax [S] Vmax
= +�
V is the reaction velocity. Vmax is the maximum reaction velocity. Km 
is the Michaelis constant (substrate concentration at half-maximal 
reaction velocity) and [S] is the substrate concentration [5].
RESULTS AND DISCUSSION
In this study, the kinetic parameters of MPO with and without the 
presence of some cosubstrate in saliva of newborn at risk of sepsis were 
investigated. Kinetic parameters of salivary MPO were determined using 
Lineweaver-Burke plot. From this plot, a Michaelis-Menten equation used 
to determine the Km and Vmax values for both groups with and without 
the presence of different cosubstrates (Figs. 1 and 2 and Table 1). From 
Fig. 1 and Table 1, the Vmax of the salivary MPO in healthy newborns 
group ranges from 0.035 to 0.041 s 1, while the Vmax values in sepsis 
newborn group are within the range of 0.035–0.043 s 1. Furthermore, 
from Fig. 2 and Table 1, the Km values in healthy newborn group are 
within the range of 0.070–0.0.235, while the Km values in sepsis newborn 
group are within the range of 0.064–0.338. The highest Vmax values was 
found in Group 3 of healthy newborn group, while in the sepsis newborn 
group was found in Group 4. However, the Vmax values were found not 
much different between each group. The highest Km values were found 
Group 1 of both healthy and sepsis newborn, while the lowest Km values 
were found in Group 2 of healthy newborn and Group 3 of sepsis newborn.
To the best of our knowledge, the Vmax value illustrates the ability of an 
enzyme to catalyze the substrate, and the Km value illustrates enzyme 
and substrate affinity. From this point of view, the higher value of Vmax 
reflects a better enzyme’s ability to catalyze its substrate. In contrast to 
the Vmax value, a higher Km value reflects the low affinity of the enzyme 
against its substrate. This means, the reaction will shift to the left. The 
shift in the reaction results in a decrease in the product level [12-14].
Table 1: Kinetic parameters (Km and Vmax) and coefficient 
correlation for salivary MPO in different groups in normal and 
sepsis newborn. Group 1: Saliva and H2O2; Group 2: Saliva, H2O2, 




Normal 1 0.235 0.035 0.981
2 0.070 0.037 0.960
3 0.216 0.039 0.917
4 0.080 0.041 0.984
Sepsis 1 0.338 0.035 0.951
2 0.064 0.039 0.907
3 0.080 0.039 0.941
4 0.148 0.043 0.981
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Fig. 2: The Km value comparison of salivary myeloperoxidase 
between groups in normal and sepsis conditions. Group 1 
contains saliva and hydrogen peroxide (H2O2); Group 2 contains 
saliva, H2O2, and NaCl; Group 3 contains saliva, H2O2, and KI; and 
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Fig. 1: The Vmax value comparison of salivary myeloperoxidase 
between groups in normal and sepsis conditions. Group 1 
contains saliva and hydrogen peroxide (H2O2); Group 2 contains 
saliva, H2O2, and NaCl; Group 3 contains saliva, H2O2, and KI; and 
Group 4 contains saliva, H2O2, and SCN
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Results of this present study indicated that the addition of some 
cosubstrate does not affect the catalytic ability of MPO both in normal or 
sepsis condition. However, different things happen at Km value. According 
to our results, it seems sepsis condition decreases the affinity between 
MPO and H2O2. It can be seen from the higher value of Km in sepsis group 
compare to normal group without the addition of some cosubstrate. 
Interesting results can be found at the value of Km after some cosubstrate 
additions. In sepsis condition, the additions of some cosubstrate seem to 
increase the affinity between MPO and the substrate and cosubstrate. 
The strongest affinity of MPO was found in chloride addition.
The increasing of affinity of MPO in sepsis condition means the binding 
between MPO and H2O2 might be stronger by the presence of those 
cosubstrates. This condition will increase the concentration of HOCl, 
hypothiocyanite acid, and HOI as a product. Between these three 
products, it seems MPO rather to oxidize chloride than the two others. 
It can be seen from the lowest Km value in chloride group than another 
group. To the best of our knowledge, as far as we are aware, this the first 
study of MPO kinetic parameter analysis in saliva of newborn at risk of 
sepsis. However, several previous studies only stated that there was an 
increasing level or activity of MPO in saliva and plasma of newborn at 
risk of sepsis [6,14-16].
It is well known that MPO is a heme enzyme that uses H2O2 to oxidize 
some cosubstrate including Cl−, I−, Br−, and SCN−. The activity of MPO to 
oxidize those cosubstrates is relatively non-specific. However, between 
those cosubstrates, Cl− was accepted as a physiological cosubstrate 
because a higher concentration in plasma than another cosubstrate. 
This is in line with our results study. The result of this present study 
indicated that with the present of Cl−, I−, and SCN−, MPO rather to oxidize 
Cl− than I− and SCN− [9]. The production of HOCl, HOI, and HOSCN by 
MPO is essential in host defense mechanisms. These productions deploy 
bactericidal activity on the bacteria ingested in the phagosome [17].
CONCLUSION
From this present study, it can be concluded that the addition of some 
cosubstrates in sepsis condition will lead to decrease the Km value 
of MPO, but not Vmax. It seems the presence of some cosubstrates in 
sepsis condition will activated MPO to catalyze the oxidation of Cl−, 
I−, and SCN−, which is important to killing the bacteria during sepsis 
condition. The result also shows that in sepsis condition, MPO will 
oxidize Cl− to form HOCl than another cosubstrate.
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